About: SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.48 (-4.13%)
SABSNASDAQSAB Biotherapeutics Inc
SAB Biotherapeutics Inc share price
SABS price activity
Last Price
$3.480
Change (24hr)
-0.15 USD (-4.13%)
Volume
200.75K
Volume (4w avg)
-
Open
$3.61
Day Range
$3.47 - $3.65
Previous Close
$3.63
Last Trade
09 Sep, 8:01 pm GMT+0
Delayed
09 Sep, 8:01 pm GMT+0
SABS price performance
Delayed
09 Sep, 8:01 pm GMT+0
SABS Market Signals